info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Use of levodopa decarboxylase inhibitor

PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC N04BA02

1 out of 7 registries used, show all original rules.

4053

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

4053

diagram downward connector

Include endpoints None

4053

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

3941

diagram downward connector
PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 3941 1583 2358
Unadjusted prevalence (%) 0.96 0.69 1.30
Mean age at first event (years) 69.43 68.20 70.26

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: PDMED_LEVODOPA_DECARBOXYLASEINHIBITOR – Use of levodopa decarboxylase inhibitor
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Use of levodopa decarboxylase inhibitor

Endpoint not on priority list, no data to show.